Next-Generation Antibodies and Protein Analysis (2nd Edition)


The Next Generation Antibodies and Protein Analysis: Tools and Technologies meeting (NGAPA) in June 2015 was a great success and we are pleased to announce the 2nd edition in October, 2017. The symposium will bring together some of the most highly regarded Academics and Companies in the world with novel technologies in several sessions, with topics focused on:

Protein Modifications
Single Domain and Recombinant Antibody tools
Next-Generation Affinity Reagents
Bio-sensing and molecular interactions
Single-Cell technologies
Protein design

Catalyzed by VIB’s Technology Scouting team, the Tools and Technologies meetings focus on the front end of innovation and bring together key innovators in selected life sciences research fields. The Next-Generation Antibodies and Protein Analysis conference is set to make another world class meeting, bringing together an exciting selection of top speakers and newly emerged companies. In addition to great scientific and technology program, the conference will provide ample networking opportunities.


Abstract submission: August 18, 2017
Early Bird registration: September 04, 2017
Final Deadline: October 02, 2017

Register here.



Mathias Uhlén, KTH, SE

Jürgen Cox, Max Planck Institute of Biochemistry, DE

Akhilesh Pandey, Johns Hopkins, US

Anne-Claude Gavin, EMBL, DE

Gilles Travé, IGBMC, FR

Sven Eyckerman, VIB, BE

Yu-Ju Chen, Institute of Chemistry, Academia Sinica, TW

Judit Villen, University Washington, US

Rune Linding, University of Copenhagen, DK

Rong Fan, Yale, US

Brenda Andrews, University of Toronto, CA

Jeroen Krijgsveld, EMBL, DE

Jan Steyaert, VIB, BE

Gijs J. L. Wuite, VU, NL

B. Kuhlman, University of North Carolina, US

Shohei Koide, University of Chicago, US

Jim Wells, UCSF, US

Possu Huang, Stanford, US

Stylianos Bournazos, Rockefeller, US

Frederic Rousseau, VIB

Sergey Piletsky, University of Leicester, UK


Guy Hermans, CSO, Isogenica, UK

Liesbeth van Oeffelen, Bioinformatician, BioSenSource, BE

Joshua Salafsky, CSO Biodesy, US

Heather Agnew, Director of Research and Development Indi Molecular, US

Daniel Martinez Molina, CSO Pelago Bisocience, SE

Claudia Escher- X, BiognoSYS, CH

Tuomas Knowles, CSO Fluid Analytics, UK

Felix Hartlepp, VP Research & Technology, Chromotek, DE

Bonnie (Hanson) Hammer, head of development, Invenra, US

Eric Feyfant, Schrödinger, US

Mark Bushfield, Abcam, UK

Jean-Christophe Rain, Hybrigenics Services SAS, FR

Joe Beechem, head R&D nanoString

Jacob Glanville, CSO Distributed Bio, US

Michael Wehr, CSO Systasy Bioscience GmbH, DE

Christian Loch, Director of Research & Development, AVMBioMed

Henrik Daub, Evotec

Kai Scheffler, BioPharma Support Expert LSMS, Thermo Fisher

Dan Mandell, GRO Biosciences

Kristopher L. Nazor, MYi Diagnostics & Discovery



Organizer: VIB Conferences

16 Oct 2017